The global Glycomics Market size is expected to reach USD 2.4 billion by 2026 registering a CAGR of 14.7%, according to a new report by Grand View Research, Inc.Rising focus on glycomics and proteomics research has led to the growth of this market. Significant investments in this field have also enabled academic researchers to develop new tools. Thus, the field of glycoscience is growing, which is a high impact rendering driver for the market. Glycans are essential in biological processes and research on them helps in understanding the biology more comprehensively, without specializing in glycobiology. According to 2018 BDO Biotech Briefing, the average R&D expenditure of the mid-sized biotech companies increased around 14% from 2016 to 2017.
Growing
drug discovery and development is leading to a rise in R&D investments by
biotech companies. Thus, the need for glycomics research techniques for
conducting comprehensive glycomes study is constantly increasing. Rise in the
number of initiatives being undertaken by the government to increase funding
for R&D has led to the increased need for glycomics techniques. The
Australian government invested around USD 10.4 billion for scientific research
activities and innovations for the period 2017-2018. The Irish Government also
announced a USD 5.6 billion spending program in 2015, which was aimed at
increasing the number of scientific research activities from 25,000 to 40,000.
Such
funding initiatives are expected to boost the demand for glycomics research
techniques in near future. Key companies are also undertaking extensive R&D
initiatives to develop new and technologically advanced products. For instance,
in 2018, Shimadzu Corp. collaborated with PREMIER Biosoft, a global company in
the field of bioinformatics solutions, with an aim to introduce its LCMS-9030
Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance
glycomics and lipidomics data research analysis. In addition, in 2016, ProZyme,
Inc. launched Gly-Q Glycan Analysis System, an integrated platform that enables
user-friendly and high-throughput glycoanalysis.
Related Press Release@ Glycomics Market Report
Glycomics Market Report Highlights
- Enzymes is
expected to be the fastest-growing segment in the global glycobiology
market due to its wide application scope in research & diagnostics and
repetitive purchase of these products
- In the application
segment, drug discovery & development accounted for the largest
revenue share in 2018 owing to high demand for personalized medicines and
focus on novel drug development
- North
America led the global glycomics/glycobiology market in 2018 and is expected
to continue its dominance during the forecast period
- Presence of
a large number of research laboratories and pharmaceutical and
biotechnology companies in North America is the major factor driving the
regional market
- Europe is
expected to register the highest CAGR from 2019 to 2026 due to rising
number of pharmaceutical and biopharmaceutical companies in the region
- Some of the
key companies include Danaher;
ProZyme; Shimadzu Corporation; Agilent Technologies; Bruker; Merck KGaA;
Takara Bio, Inc.; New England Biolabs; ThermoFisher Scientific, Inc.; and
Waters Corporation
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment